CorMedix, Inc. (CRMD)
7.05
+0.03
(+0.43%)
USD |
NASDAQ |
Apr 02, 16:00
7.06
+0.01
(+0.14%)
After-Hours: 20:00
CorMedix Market Cap : 560.48M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.533B |
| Pfizer Inc. | 159.85B |
| ANI Pharmaceuticals, Inc. | 1.626B |
| Indivior Pharmaceuticals, Inc. | 3.696B |
| Altimmune, Inc. | 433.90M |
Market Cap Related Metrics
| PE Ratio | 3.554 |
| PS Ratio | 1.815 |
| Price to Book Value | 1.375 |
| Price to Free Cash Flow | 3.275 |
| Price | 7.05 |
| Earnings Yield | 28.13% |
| Operating PE Ratio | 3.768 |
| Normalized PE Ratio | 3.54 |